troikaa
Excellence built on basics
Innovation -- Quality -- Services
 
Dynapar Aq 75mg / 1ml Injection

 

dynapar aq 75mg / 1ml
 

Description:

Recognition  &  Reward for innovation:
More Patent for Dynpar AQ 1ml Inj. for OAPI region which represent Benin, Burkina Faso, Cameroon, Central Africa Republic, Chad, Congo, Equatorial Guinea, Gabon, Guinea, Guinea Bissau, Ivory Coast, Mali, Mauritania, Niger, Senegal and Togo countries.

Dynapar AQ 75mg / 1ml (The 8th wonder) received its SECOND patent from Myanmar. South Africa is the FIRST country to recognise the innovation and grant patent to Dynapar 1ml.

We have filed in 99 countries. The patent grant procedure involves application (in various countries), examination by the patent office of the respective country, and if all found ok, acceptance and grant of the patents. SA is the first country where the process is over. More acceptances and grants of our patent for DRAQ 1ml will occur in coming months.

"The only diclofenac injection available in PFS (Pre filled Syringe)".

For the first time in the world, Diclofenac 75mg / 1ml injection is introduced for the management of acute pain. Unlike conventional diclofenac, 1ml Dynapar AQ Inj. can be given intra-deltoid as well. Multicentric clinical studies have proven the efficacy and safety of 75mg/1ml Diclofenac injections. Bioequivalence studies show that Dynapar AQ 1ml inj. offers higher bioavailability compared to conventional 3ml Diclofenac inj. Studies show that majority of intra-gluteal injections may actually be subcutaneous and the rate of absorption is faster when given intradeltoid rather than intra-gluteal. Moreover smaller volume of concentrated solution cause less muscle damage compared to larger volume of relatively less concentrated solution.

dynapar aq 75mg / 1ml
 

Indication:

  • DYNAPAR AQ 75mg/1ml is indicated in management of acute pain including post-operative pain

Brand Availability:

Brand
Composition
Features
Presentation
Packing
DYNAPAR AQ 75mg/1ml
Diclofenac sodium
75mg/1ml inj.

DYNAPAR 75mg/1ml is introduced for the first time in World, a 1ml Diclofenac inj.

Dynapar AQ 1ml offers:

1) Significantly higher bioavailability
2) Can be given intradeltoid, over and above intragluteal and as I.V infusion
3) Convenient to administer
1ml
ampoule
10 ampoules of 1ml
in a blister. 5 such blisters in 1 box.
ie. 50 ampoules
in 1 box